(2'S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,9R)-9-(hydroxymethyl)-4a,6a-dimethyl-4,4a,4b,5,6,6a,7a,8,8a,8b,8c,9-dodecahydro-3H,3'H-spiro[cyclopropa[4,5]cyclopenta[1,2-a]phenanthrene-7,2'-furan]-5'(4'H)-one
Drospirenone EP Impurity I is a fully characterized chemical compound used as a reference standard of API Drospirenone. The standard offered is compliant with regulatory guidelines. Drospirenone EP Impurity I is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 2896199-04-3
Related products
6ß,7ß,15ß,16ß-Dimethylene-3ß,5ß-dihydroxyandostan-17-one
M.F.
M.W. 330.47
CAT# AR-D02487
CAS# 82543-16-6
3β,5β-Dihydroxy-15β,16β-methylene-androst-6-en-17-one
M.F.
M.W. 316.44
CAT# AR-D02491
CAS# 82543-15-5
